CR20170522A - PEPTIDES AND COMBINATION OF NOVELED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS - Google Patents
PEPTIDES AND COMBINATION OF NOVELED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORSInfo
- Publication number
- CR20170522A CR20170522A CR20170522A CR20170522A CR20170522A CR 20170522 A CR20170522 A CR 20170522A CR 20170522 A CR20170522 A CR 20170522A CR 20170522 A CR20170522 A CR 20170522A CR 20170522 A CR20170522 A CR 20170522A
- Authority
- CR
- Costa Rica
- Prior art keywords
- peptides
- combination
- present
- noveled
- tumors
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 238000009169 immunotherapy Methods 0.000 title abstract 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 230000005975 antitumor immune response Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se relaciona con péptidos, proteínas, ácidos nucleicos y células para su uso en métodos inmunoterapéuticos. En particular, la presente invención se relaciona con inmunoterapia para el cáncer. La presente invención se relaciona además con epitopes de péptidos de células T asociados con tumores, solos o en combinación con otros péptidos asociados con tumores que pueden, por ejemplo, servir como ingredientes farmacéuticos activos de composiciones para vacunas que estimulan la respuesta inmune antitumoral o para estimular células T ex vivo y transferirlas a pacientes. Los péptidos unidos a moléculas del complejo de histocompatibilidad principal (MHC) o los péptidos como tales también pueden ser el blanco de anticuerpos, receptores de células T solubles y otras moléculas de uniónThe present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to immunotherapy for cancer. The present invention further relates to epitopes of T-cell peptides associated with tumors, alone or in combination with other peptides associated with tumors that may, for example, serve as active pharmaceutical ingredients for vaccine compositions that stimulate the antitumor immune response or for stimulate ex vivo T cells and transfer them to patients. Peptides bound to molecules of the major histocompatibility complex (MHC) or peptides as such may also be the target of antibodies, soluble T cell receptors and other binding molecules
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2016/056557 WO2016156202A1 (en) | 2015-03-27 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| EP16056557 | 2016-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20170522A true CR20170522A (en) | 2018-12-21 |
Family
ID=65236531
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20200472A CR20200472A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20200474A CR20200474A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20170522A CR20170522A (en) | 2016-03-24 | 2016-03-24 | PEPTIDES AND COMBINATION OF NOVELED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS |
| CR20200477A CR20200477A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20200473A CR20200473A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20200475A CR20200475A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20200472A CR20200472A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20200474A CR20200474A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20200477A CR20200477A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20200473A CR20200473A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| CR20200475A CR20200475A (en) | 2016-03-24 | 2016-03-24 | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
Country Status (1)
| Country | Link |
|---|---|
| CR (6) | CR20200472A (en) |
-
2016
- 2016-03-24 CR CR20200472A patent/CR20200472A/en unknown
- 2016-03-24 CR CR20200474A patent/CR20200474A/en unknown
- 2016-03-24 CR CR20170522A patent/CR20170522A/en unknown
- 2016-03-24 CR CR20200477A patent/CR20200477A/en unknown
- 2016-03-24 CR CR20200473A patent/CR20200473A/en unknown
- 2016-03-24 CR CR20200475A patent/CR20200475A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CR20200475A (en) | 2021-01-26 |
| CR20200472A (en) | 2021-01-26 |
| CR20200473A (en) | 2021-01-25 |
| CR20200477A (en) | 2021-01-26 |
| CR20200474A (en) | 2021-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR127117A2 (en) | NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | |
| CL2023001346A1 (en) | Use of peptides in immunotherapy against small cell lung cancer and others. | |
| CL2021002459A1 (en) | Peptides and peptide combinations for use in cancer immunotherapy (divisional of application no. 201902093) | |
| MX2021015933A (en) | PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER TYPES OF CANCER. | |
| MX2022005060A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers. | |
| MX2017017145A (en) | NOVELTY PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCER OF OVARY AND OTHER CANCERES. | |
| CR20220115A (en) | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (Div. 2017-522) | |
| MX2018004140A (en) | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST MICROCELLULAR LUNG CANCER AND OTHER TYPES OF CANCER. | |
| MX2020012777A (en) | NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS TO CREATE SUPPORTS FOR USE AGAINST PANCREATIC CANCER AND OTHER TYPES OF CANCER. | |
| CR20210234A (en) | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers | |
| CR20200495A (en) | NEW PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER (Divisional 2018-174) | |
| CR20200592A (en) | Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers | |
| CR20200561A (en) | Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers | |
| MX2017017148A (en) | NOVEDOUS PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOFAGIC CANCER AND OTHER CANCERES. | |
| CO2019012077A2 (en) | Peptides and combinations thereof for use in immunotherapy against various types of cancer | |
| CL2024000530A1 (en) | Peptides and combinations, their use in immunotherapy against lung cancer and other cancers | |
| MX2019012226A (en) | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers. | |
| MX2022002263A (en) | NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA AND OTHER TYPES OF CANCER. | |
| CL2021000177A1 (en) | Peptides, peptide combinations, cells and kits for use in cancer immunotherapy (divisional application no. 201802360) | |
| MX2022005570A (en) | NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREAS CANCER AND OTHER TYPES OF CANCER. | |
| CL2021001010A1 (en) | Peptides and peptide combinations for use in immunotherapy against small cell lung cancer and other types of cancer (divisional application no. 201800780) | |
| CR20170522A (en) | PEPTIDES AND COMBINATION OF NOVELED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | |
| AR121812A2 (en) | PEPTIDE, EXPRESSION VECTOR, HOST CELL, ACTIVATED T-LYMPHOCYTE, ANTIBODY, T-CELL RECEPTOR, PHARMACEUTICAL COMPOSITION, KIT AND RELATED METHODS | |
| AR105252A1 (en) | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGIC CANCER AND OTHER CANCER |